The FDA has said it will expand unannounced inspections of overseas manufacturing facilities supplying medicine and other medical products to the US. The aim is to make sure that foreign companies ...
Equipment to address Annex 1 compliance, scale-up for visual inspection recipes and assembly processes, and OSD production. At Interphex, Syntegon will showcase pharma and biopharma solutions designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results